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ABSTRACT 
 
Here we describe a detailed methodology to study the function of genes whose products function during mitosis by dsRNA-mediated 
interference (RNAi) in cultured cells of Drosophila melanogaster. This procedure is particularly useful for the analysis of genes for which 
genetic mutations are not available or for the dissection of complicated phenotypes derived from the analysis of such mutants. With the 
advent of whole genome sequencing it is expected that RNAi-based screenings will be one method of choice for the identification and 
study of novel genes involved in particular cellular processes. In this paper we focused particularly on the procedures for the proper 
phenotypic analysis of cells after RNAi-mediated depletion of proteins required for mitosis, the process by which the genetic 
information is segregated equally between daughter cells. We use RNAi of the microtubule-associated protein MAST/Orbit as an 
example for the usefulness of the technique. 
 
 
INTRODUCTION 
 
In many species, cellular uptake of double-stranded RNA 
(dsRNA) induces a potent and specific gene silencing, a 
phenomenon known as RNA interference or RNAi. Gene 
silencing through RNAi was first discovered after the 
introduction of dsRNA into C. elegans and it was demonstrated 
that gene expression was suppressed very efficiently in a 
homology-dependent manner (1). RNAi seems to act in a post-
transcriptional pathway, targeting RNA transcripts for 
degradation, and is related to the previously known phenomenon 
of co-suppression in plants (for reviews on the detailed 
mechanism of RNAi see refs. 2-5). With the advent of whole 
genome sequencing, RNAi has become a quick and powerful tool 
for the genome-wide study of gene function (6-9).  
 
Following the development of RNAi methods in C. elegans, RNAi 
was then shown to be highly effective in Drosophila embryos (10-
11). Subsequent studies demonstrated that RNAi could efficiently 
knock down the levels of specific proteins in several Drosophila 
tissue culture cell lines (12). More recently, the discovery of short 
small interfering RNAs has led to the wide-scale application of 
this approach to a wide variety of mammalian cell lines (13) and 
S. pombe (R. Allshire, personal communication), however S. 
cerevisiae appears to have lost this pathway.  
 
In  Drosophila tissue culture cell lines, RNAi has been used 
successfully in the study of mitosis and cytokinesis (14-20) and 
the method has become a prominent tool in Drosophila cell cycle 
research. The advantages of using Drosophila cell lines for RNAi 
studies of mitosis include the sequenced and well annotated 
genome with a relatively high genetic conservation with humans 
(21), the favourable cytogenetics for the study of chromosomal 
processes (Drosophila has only 4 chromosomes), the existence of a 
great number of reagents to visualize the mitotic apparatus, the 
ability to use a PCR approach to obtain dsRNAs rather than the 
necessity to purchase expensive oligonucleotides or construct 
complex vectors (as in mammalian cells), and the ease of cell 
culture, with cells grown at 25°C without any supplementary 
requirements for CO2 and at relatively low cost. Additionally, 
RNAi could be use to simultaneous knock down the levels of 
expression of more than one gene, therefore providing a useful 
tool for the dissection of signalling pathways. Due to these 
reasons, one can predict a great boom of RNAi-based genomic 
screenings using Drosophila tissue culture cells in the upcoming 
years (22). Maiato et al.    
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However, interpretation of results after RNAi in Drosophila tissue 
culture cells can be complex since the penetrance of RNAi is not 
absolute, these cells are hard to synchronize, live cell analysis is 
not yet well developed and the resulting phenotypes can often be 
heterogeneous. Here we describe a detailed methodology for the 
careful phenotypic interpretation after specific gene inactivation 
by RNAi in Drosophila  tissue culture cells, with particular 
emphasis on one gene involved in mitosis. The gene in cause, 
encodes for a conserved microtubule-associated protein called 
MAST/Orbit that, during mitosis, is localized to the mitotic 
spindle, centrosomes and kinetochores, ending up accumulating 
in the central-spindle region and ultimately concentrating at the 
midbody (23-24). Mutations in mast show severe mitotic 
abnormalities including the formation of mono- and multi-polar 
spindles organized by clusters of centrosomes (23). The use of 
RNAi in Drosophila tissue culture cells was of great help in the 
dissection of the mitotic role of MAST/Orbit, namely its 
unexpected role in the behavior of kinetochore microtubules (17, 
25). 
 
MATERIALS AND METHODS 
 
Cell lines 
 
RNAi has been shown to be effective in a wide variety of 
Drosophila tissue culture cells, including the S2, Dmel2, Kc and 
BG2-C6 lines (see for example ref. 15 and 26). Importantly, the 
penetrance of the RNAi appear to depend on the cell line used, 
with S2 cells thus far yielding the best results in our experiments 
(Fig. 1D).  
 
S2 cells can be grown in plastic fl ask s a t 2 5 °C i n  Sch n ei de r’s  
Drosophila medium (Gibco) supplemented with 10% FBS. For 
the RNAi experiment, the cells must be in exponential growth. 
This can be achieved by diluting the cells 1/5 into new media 
every 3-4 days.  
 
Preparation of dsRNA 
 
Drosophila cells respond to the presence of large dsRNAs by 
shutting down protein translation, but mammalian cells do not. 
This greatly simplifies the process and lowers the cost of RNAi 
in Drosophila cells, as it is not necessary to purchase custom 
oligonucleotides or construct complex vectors. Instead, the first 
step towards to specifically knocking down the expression of a 
Drosophila protein of interest by RNAi is to synthesize a dsRNA 
fragment of ~700 bp (although we have also succeeded using 
smaller or larger fragments). For this purpose, we designed 
~18mer sequence specific oligos to amplify a PCR product of 
~700 bp from the cDNA of interest that is cloned into a 
plasmid. In order to generate the dsRNA from the PCR 
products, these primers must incorporate a 5’ T7 RNA 
polymerase minimum binding site (Table 1).  
 
The successful choice of the optimal sequence fragment seems to 
be random, however we have found that starting in the 5’-UTR 
covering the codon for the first methionine may in some cases 
improve the specific silencing of the protein of interest.  
Table 1: Primer sequences used for the preparation of the PCR 
product used for in vitro RNA transcription of MAST/Orbit. The 
sequence corresponding to the T7 RNA polymerase-binding site 
is underlined. 
Primer Sequence 
Forward TAATACGACTCACTATAGGG GAAGGACGAATAGACATT 
Reverse TAATACGACTCACTATAGGG TCCTGTTTGACCTGGTCG 
 
We then prepare 10-12 PCR reactions, each containing 0.5-1 ng 
of template plasmid DNA containing the cDNA of interest, 1µM 
of each primer, 2.5 mM of dNTP mix, 2.5 U of Taq polymerase 
(Boehringer), enzyme buffer supplemented with Mg2+ according 
to the manufacturer and water for a final volume of 100 µl/PCR 
reaction. We use the following PCR program: 94oC for 2 min 
(hot start), add Taq polymerase and then do 30 cycles of 94oC – 
30 s; 55oC – 60 s; 72oC – 60 s, followed by 72oC for 10 min. The 
PCR products are purified using the PCR Clean-Up kit (MoBio) 
according to the manufacturer’s instructions (3 PCR reactions 
can be run through each column). We test the efficiency of the 
PCR by electrophoresis by running 1 µl of the pure PCR product 
on a 1% agarose gel (Fig. 1A). The purified DNA is then 
quantified by checking the optical density at 260 nm and adjusted 
to a concentration of 150 ng/µl or higher. This will be used as 
the template for preparation of dsRNA in vitro. For this purpose 
we normally do 10 reactions per RNA using the MEGAscript T7 
kit (Ambion) with the following modification to the 
manufacturer’s instructions: instead of the recommended 
incubation time for transcription at 37°C, we usually get better 
yield using longer incubation times of at least 6 h. The reactions 
are then pooled into a single tube and the RNA precipitated with 
LiCl (provided with the kit) and followed by 2 washes in 70% 
ethanol. The pellet is visible as a sloppy whitish precipitate and, 
after air-drying, is then re-suspended in 100 µl of nuclease-free 
water. The RNA concentration can be determined as before and 
should be 2-3 µg/µl or higher.  
 
Another reliable alternative to prepare the RNA is to clone the 
DNA template into transcription vectors like pSPT18 and 
pSPT19 (Boehringer), which already contain the promoter 
sequence for T7 RNA polymerase, and in vitro transcribe both 
sense and anti-sense mRNA. To denature secondary structures, 
the RNA is then heated for 30 min in a beaker containing about 
200 ml of water at 65°C, and then left to slowly cool down to 
room temperature to form the dsRNA duplexes. Next, 1 µl is 
tested by electrophoresis in a 1% agarose gel (Fig. 1B). The 
dsRNA can finally be stored at -20oC for several months. 
 
For control experiments, it is best to perform the RNAi 
experiment with an irrelevant dsRNA, in order to control for 
effects of the exposure of the cells to dsRNA. In our laboratory, 
we have typically done this by using dsRNA corresponding to a 
fragment of a human intron, and chosen at random (15). 
Alternatively, the use of dsRNA against a coding region of a 
protein known not to be involved in mitosis could also help to 
discard unspecific effects. 
 Maiato et al.    
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RNAi experiment 
 
For a typical RNAi experiment, we diluted exponentially growing 
S2 cells in Schneider’s Drosophila medium (Gibco) without serum 
and placed them in 6-well plates (chamber diameter 35 mm) at a 
final concentration of 106 cells/ml/well. Two wells were set up 
for each time point, one for the RNAi experiment and one for 
the control. As a first step, it is advisable to titrate the minimum 
amount of dsRNA required for maximum depletion of the 
protein of interest. If too little dsRNA is added the RNAi is 
ineffective, however too much dsRNA may be toxic to cells as it 
was described in zebrafish where it can cause non-specific 
deffects during development (27). In general, it is desirable to 
perform the experiments using a dsRNA concentration near the 
upper end of the tolerated range, as increasing the amount of 
dsRNA added to the culture can cause the depletion to occur at 
earlier time points during the experiment. We typically tested a 
range from 15 µg to 50 µg of dsRNA per well, and observed that 
addition of 30 µg was usually sufficient for complete depletion of 
the proteins of interest without causing obvious toxic side effects 
to the cells. Of course, this kind of experiment requires high 
sensitivity by the experimenter in order to distinguish between a 
real phenotype from a side effect, which can be helped by 
comparison with known mutant phenotypes when these are 
available.   
 
After addition of the dsRNA to the cells, the dish was swirled to 
allow uniform distribution. In order to cut down possible 
pipeting errors or contamination, the dsRNA could be added 
directly to the cells before distributing them into individual wells. 
Concomitent with the addition of the dsRNA, cells were serum 
starved for 1 h at room temperature. This promotes 
incorporation of the dsRNA by an as-yet unknown mechanism. 
Subsequently, 2 ml of Schneider’s Drosophila  medium 
supplemented with FBS were added to each well and the cells 
returned to the incubator at 25°C.  
 
To prepare protein extracts for analysis, cells from both RNAi 
and control experiments were collected at each time point and 
counted using a haemocytometer. The cells were then pelleted by 
centrifugation at 1,500 rpm for 4 min, re-suspended directly into 
an appropriate volume of Laemmli sample buffer sufficient to 
enable the loading of 106 cells/lane on the gel, lysed by 
sonication, boiled for 5 min and stored at -20°C. At the end of 
the experiment the collected samples for each time point were 
subjected to SDS-PAGE. The efficiency of silencing was 
determined by immunoblotting with a specific antibody (Fig. 1C) 
using the ECL detection system (Amersham). Quantitation was 
performed by visual comparison of signal intensity relative to that 
of a titration series as described next. 
 
Antibody characterization 
 
RNAi is not an absolute technique. Not all cells silence the gene 
in question, and silencing can occur to different extents in 
adjacent cells in the population. It is therefore important, if at all 
possible, to have a specific antibody recognizing the protein to be 
silenced. This, of course, is a drawback in large-scale RNAi 
studies, where one explanation for the absence of a phenotype 
m u s t  a l w a y s  b e  t h a t  t h e  p a r t icular RNAi approach was not 
effective. In extraordinary circumstances where antibodies are 
not available, the effectiveness of RNAi can be determined by 
preparing stable cell lines expressing the protein of interest fused 
to green fluorescent protein (GFP). Success of the RNAi 
procedure can then be monitored by following the loss of GFP 
signal. 
 
The first step towards assessing the effectiveness of the RNAi is 
to titrate the antibody against a range of cell concentrations. This 
is done by immunoblotting against cell extracts where each lane 
contains proteins from a differing number of cells. For example, 
we typically electrophorese a range of concentrations of protein 
extracts from between 104 and 5 x 106 cells per lane. This enables 
us to determine the minimum number of cell equivalents that can 
be detected by the antibody in question, and when compared 
with the signal obtained after RNAi, enables us to estimate the 
degree of silencing obtained. 
 
To monitor the protein levels after addition of dsRNA in the cell 
culture, we collected samples every 24 h, which is roughly the 
doubling time for S2 cells (21 h in the case of Dmel2 cells). 
Usually, 106 cells for each time point are enough for antibody 
detection, but this may need to be adjusted depending on the 
protein of interest. Also indispensable is a loading control that is 
typically an abundant structural protein like actin or tubulin, for 
which commercial antibodies are available (Sigma).  
 
Indirect immunofluorescence  
 
Detection of the initial phenotype resulting from addition of 
dsRNA to the cell culture is an important goal of the RNAi 
experiment. However, this can often be very tricky, especially for 
proteins that have multiple roles in a cellular process, as is often 
the case for regulatory proteins such as kinases or phosphatases. 
Ideally, in order to minimize heterogeneity between different cell 
populations, a small aliquot of cells from each time point used for 
immunoblotting should be used for immunofluorescence 
analysis. Nevertheless, this problem can be minimized by 
collecting, from a parallel experiment, samples at several time 
points after addition of the dsRNA to the culture followed by 
analysis by immunofluorescence using appropriate antibodies 
(again, samples must be collected from both RNAi and control 
experiments at each time point). For this purpose we repeated the 
same procedures described for the immunoblot, but using LAB-
TEK permanox 2-chamber slides from Nalge Nunc (distributed 
by Gibco). Due to the size of the chambers, we used 5 x 105 
cells/0.5 ml of media/chamber, and added half the amount of 
dsRNA used for the immunoblot experiment (in this case 15 
µg/chamber), with one chamber used for the experimental and 
the other for the corresponding control. After serum starvation 
for 1 h, 1 ml of Schneider’s Drosophila  medium supplemented 
with FBS was added to each chamber and the slides were 
returned to the incubator at 25°C. As S2 cells grow in suspension 
it was necessary at each time point to centrifuge cells onto the 
slides for 15 min at 4,000 rpm at room temperature to render 
them adherent. Maiato et al.    
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Fig. 1: Preparation of dsRNA and specific protein depletion. (A) PCR 
fragment of ~700 bp synthesized from MAST/Orbit cDNA. (B) Corresponding 
dsRNA obtained by in vitro transcription using the previous PCR fragment as 
template. The lower band corresponds to ssRNA that did not form duplexes. (C) 
Monitoring of protein levels upon addition of 30 µg of dsRNA to the cells by 
immunoblot using MAST polyclonal antibodies and anti-α-tubulin monoclonal 
antibodies as a loading control. (D) Determination of the amount of dsRNA 
necessary to deplete MAST from S2 and Dmel2 cells. Protein levels were 
monitored 120 h after addition of dsRNA. It is clear that for the case of MAST, 
protein depletion is significantly more effective in S2 cells. (E) Addition of 
dsRNA to S2 cells did not cause a significant effect upon cell viability throughout 
the experiment. 
 
Alternatively, the cells could be grown in 6 well plates as 
described for the immunoblot, and at each time point cytospun 
or left to adhere for 2 hours onto sterile poly-L-lysine treated 
slides (BDH). Cells were then immediately fixed and 
permeabilized and processed for immunofluorescence. 
Alternatively, after fixation, cells can be kept in PBS at 4°C up to 
one week and the complete set of cells from each time point 
processed at the same time for immunofluorescence (Fig. 2). In 
the case of MAST RNAi, the first visible abnormality that we 
observed was an increase in the mitotic index caused by the 
accumulation of cells in a prometaphase-like stage. Among these 
prometaphase cells, we observed two distinct populations, those 
with monopolar spindles (Fig. 2B and 2F) and those in which the 
spindle was bipolar but on which the chromosomes could not 
align at a metaphase plate (Fig. 2G). We defined these as the 
primary consequences due to MAST depletion. These results 
were confirmed independently by in vivo analysis of mast mutant 
embryos (17). 
 
A number of other phenotypes could be observed at later time-
points. These included the formation of polyploid cells with 
multiple centrosomes (Fig. 2C) and the appearance of anaphase-
like cells with two distinct sets of segregated chromosomes 
separated on a bipolar spindle (Fig. 2D and 2H). These cells 
frequently display both centrosomes abnormally clustered at a 
single pole (Fig. 2D). After completion of the studies described 
here, Vale and co-workers published that S2 cells will adhere 
strongly and spread out on cover slips coated with concanavalin 
A (18). We have not yet tested the efficacy of RNAi in such 
adherent cells, but this is potentially a significant advance, at least 
with regard to the morphological analyses. However, we do know 
that this technique seriously compromise cytokinesis in S2 cells 
(P. Sampaio, personal communication). 
 
Because not all cells are affected equally by the RNAi procedures, 
the culture at each time point is a mixture of cells in which the 
target protein has been depleted and cells in which it is still 
present. This makes description of the phenotype difficult, as 
some cells are affected and others are not. If cells are stained for 
the protein that is being targeted, then phenotypic analysis can be 
limited to those cells in which the treatment has been effective 
(i.e. in which the target protein is severely depleted or 
undetectable). This greatly simplifies the data analysis.  
 
Growth curves and cell viability 
 
A simple and quick assay to assess for cell viability in the RNAi 
experiment is to stain a small sample of cells at each time point 
with trypan-blue (Sigma). This method relies on the alteration of 
membrane integrity as determined by the uptake of dye by dead 
cells that turn out blue. In the case of MAST RNAi, when 
compared with controls and RNAi of other proteins (INCENP 
and Aurora B), cell viability throughout the experiment typically 
did not change significantly (Fig. 1E). 
 
The growth curves corresponding to the RNAi and control 
experiments must take into consideration only the number of 
viable cells, and the doubling time of the population is given by 
the slope of the best fit (semi-log scale) that can be calculated 
from the corresponding exponential equations.  
 
Determination of the mitotic index and 
quantification of mitotic parameters 
 
One can find many ways of determining the mitotic index of a 
cell population described in the literature, for example: number 
of mitotic cells per optical field, number of cells positive for Maiato et al.    
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phosphorylated histone H3 over the total number of cells or 
number of mitotic cells scored by direct visualization over the 
total number of cells. In our experiments, the mitotic index is 
calculated as the percentage of total cells that are in mitosis, and 
can typically be scored accurately by direct observation of 100-
200 cells. 
 
 
Fig. 2: Immunofluorescence analysis of mitotic S2 cells after RNAi. 
Chromosomes were stained with DAPI (blue), microtubules were stained with an 
anti-α-tubulin antibody (green), centrosomes were stained with an anti-CP-190 
antibody and the centromeres were stained with an anti-CID antibody (both 
white or red in the merged images). (A, A’ and E, E’) Control metaphase cells 
showing a well organized bipolar spindle with one centrosome at each pole and 
with the chromosomes correctly aligned at the metaphase plate. (B, B’ and F, F’) 
72 h after RNAi, cells form monopolar spindles with the centrosomes clustered in 
the centre and the centromeres dispersed in the monoaster. (C, C’) Polyploid cell 
96 h after RNAi showing multiple centrosomes. (G, G’) Cell showing abnormal 
chromosome congression 72 h after RNAi. (D, D’) Abnormal anaphase-like cells 
120 h after RNAi showing a bipolar spindle where the centrosomes are clustered 
at only one of the poles. (E, E’) Another anaphase-like cell where non-disjoined 
chromosomes have attempted to segregate towards opposite poles. Scale bar is 5 
µm. 
 
We have used a combination of DNA and tubulin staining to 
accurately identify mitotic cells from prophase through telophase. 
In some cases, staining with an antibody to histone H3 
phosphorylated on serine10 can be used to identify mitotic cells 
from prophase through anaphase, however RNAi of certain 
proteins (like INCENP and Aurora-B) causes a loss of phospho-
H3 staining (14-15).  
 
In some cases, it is desirable to assess the distribution of mitotic 
cells amongst the different phases of mitosis. This is informative 
if, for example as in the case of the INCENP or Aurora-B RNAi, 
cells have difficulty in aligning their chromosomes and 
accumulate in prometaphase (15). We have typically performed 
such analyses only on cells stained for the target protein, and 
limited our conclusions to cells in which this protein was below 
the level of detectability. 
 
DISCUSSION AND PERSPECTIVES 
 
While genetic analysis in Drosophila remains one of the most 
powerful methods to determine the function of a particular 
protein involved in cell division (reviewed in ref. 28), this is not 
always possible due to the lack of mutations for particular genes 
or due to the complexity of phenotypes observed with certain 
hypomorphic alleles. In those cases, RNAi in Drosophila  tissue 
culture cells can be an excellent alternative for the study of gene 
function. It is important to note that analysis of fixed material can 
lead to ambiguous interpretations since each fixed sample 
represents a single time point in what is a highly dynamic process. 
Live cell imaging would be of great utility for the study of mitosis 
on RNAi-depleted cells. In fact, this is now routinely performed 
for RNAi experiments using human cells. In those cases, cells are 
transfected with siRNAs or suitable vectors, then blocked in S 
phase with elevated levels of thymidine. Upon release from the 
thymidine block, cells are filmed as they enter mitosis. 
Unfortunately, this approach has yet to be developed for 
Drosophila cultured cells, where so far in vivo analysis of mitosis 
has been restricted to embryos and primary cultures of larval 
neuroblasts (29-30). 
 
This problem can be minimized for Drosophila cells by doing a 
time-course analysis after protein depletion by RNAi and 
monitoring the evolution of the phenotype using fixed material. 
This allows the investigator to follow the evolution of the 
phenotype as the cell cycle progress in the absence of a particular 
protein. In the example of MAST/Orbit mutant alleles, where 
there is a wide range of mitotic abnormalities, from monopolar 
spindles to highly polyploid cells with multiple asters, a time 
course analysis after depletion of MAST/Orbit by RNAi in tissue 
culture cells, allowed us to follow the evolution of the 
phenotypes in a null background. Our results (see ref. 17) clearly 
indicated that the first requirements of MAST/Orbit were in the 
normal congression of chromosomes into the metaphase plate 
and in the maintenance of spindle bipolarity, which contributed 
for a mitotic delay and eventual abnormal mitotic slippage 
without chromosome segregation and cytokinesis. These cells 
then must have undergone several rounds of DNA replication 
resulting in polyploidy. This phenotype could also be explained 
by the observed role of MAST at the microtubule-kinetochore 
interface, which would have direct implications in the control of 
cell cycle progression by the spindle-assembly checkpoint (for 
reviews see ref. 31). 
 
Although genome-wide RNAi based screening may provide new 
insights of protein function in cells, its results should be 
interpreted with caution. It may be misleading to deduce the role 
of a particular protein in a large-scale experiment using standard 
conditions for all the genes, since different genes  behave 
differently in response to RNAi treatment. Furthermore, the 
absence of a clear mitotic phenotype does not prove that the 
protein under study is not involved in the process. At an early 
stage in the analysis, this only indicates that the conditions used 
might not be adequate. Importantly, the results can vary 
significantly between different experiments, mostly due to the use 
of different batches of dsRNA who may have distinct Maiato et al.    
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penetrability. Apart from the phenotypes resulting from RNAi of 
a particular protein, control S2 cells also often showed a panoply 
of background mitotic abnormalities, such as bipolar spindles 
with irregular centrosome number at each pole, bipolar spindles 
with absence of centrosomes in one of the poles and monopolar 
spindles. Thus, the analysis of the control RNAi experiment can 
be very important in order to distinguish between specific effects 
arising from the RNAi, and background effects due to the 
baseline behavior of the cell line. 
 
For the analysis to be convincing, a specific antibody that works 
in both immunoblots and immunofluorescence experiments is 
also a requirement. Without such an antibody, it is not possible 
to unambiguously correlate particular phenotypes with loss of the 
protein. This is probably the strongest disadvantage relatively to 
other methods of protein inactivation, namely those that interfere 
at the DNA level (reviewed in ref. 32). Nevertheless, when 
adequately performed, RNAi in Drosophila S2 cells is certainly a 
highly effective and rapid method for the study of gene function. 
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PROTOCOLS 
 
Protocol 1: Preparation of dsRNA 
 
1.  Design 18-mer sequence-specific oligonucleotides to make a PCR product of ~700 bp from the cDNA of interest covering the 
codon for the first methionine. Don’t forget to incorporate the 5’ T7 RNA polymerase binding site in your primers 
(TAATACGACTCACTATAGGG). 
2.  Prepare 10-12 individual PCR reactions on ice containing the following reagents: 
•  0.5-1 ng of template cDNA from a plasmid 
•  1 µM of each primer 
•  2.5 mM of dNTP mix 
•  Taq polymerase enzyme buffer 
•  2 mM MgCl2 (if not included in the enzyme buffer) 
•  water to a final volume of 100 µl (take into consideration the volume of Taq polymerase that will be added afterwards) 
3.  Set up the following PCR program: 
•  94oC – 2 min 
•  add 2.5 U of Taq polymerase to the PCR reaction 
•  94°C – 30 sec 
•  55°C – 60 sec    x 30 cycles 
•  72°C – 60 sec 
•  72°C – 10 min 
 
4.  Purify the PCR products by pooling 3 reactions, and running them through each column from a PCR Clean-Up Kit (MoBio) 
according to the manufacturer’s instructions. 
5. Test  1  µl of the clean product by electrophoresis on a 1% agarose gel and quantify the DNA by measuring Abs260. The DNA yield 
can be calculated as follows: 
Abs260 x dilution factor x 50 = DNA conc. in µg/ml 
 
6.  Use this DNA as a template for in vitro RNA synthesis with the MEGA script T7 Kit (Ambion) according to the manufacturer’s 
instructions, except that the incubation time should be increased to at least 6 h. 
7.  Pool the reactions into a single tube and precipitate the RNA with LiCl according to the instructions included with the kit. 
8.  Carefully wash the pellet twice with 70% ethanol and let air-dry.  
9.  Re-suspend the pellet in 100 µl of nuclease-free water and check the RNA concentration as before but using the following 
algorithm: 
A260 x dilution factor x 40 = RNA conc. in µg/ml 
 
10.  Denature RNA secondary structures by heating at 65oC for 30 min in a beaker containing 200 ml of previously warmed water and 
then let it cool down to room temperature to make dsRNA duplexes. 
11. Test  1  µl of the dsRNA by electrophoresis in 1% agarose gel. It should run like DNA as a clean band of ~700 bp. Sometimes a 
lower band is also visible. This corresponds to ssRNA that did not make duplexes (see Fig. 1B). 
12.  Store the dsRNA at -20°C. 
 
Protocol 2: Monitoring protein depletion after RNAi by immunoblot  
 
1. Grow  Drosophila S2 cells exponentially in T-flasks at 25oC in Schneider’s Drosophila medium supplemented with 10% FBS for 4 
days. 
2.  Check how many time points and how many wells will be needed for the experiment (2 wells per time point e.g. 0, 24, 48, 72, 96, 
120, 144 hours: total of 14 wells).  
3.  Count viable cells by staining with trypan-blue (Sigma) using a haemocytometer and dilute enough cells in Schneider’s Drosophila 
medium (Gibco) without serum to make up the total volume needed for the experiment for a final concentration of 106 cells/ml. 
4.  Distribute 1 ml of media containing 106 cells per each 35 mm well (this can be done using 6 well culture plates). 
5. Add  30  µg of specific dsRNA to half of the wells, and an equivalent amount of control dsRNA to the control wells. Mix well by 
swirling and leave the cells at room temperature for 1 h to allow incorporation of the dsRNA. Maiato et al.    
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6.  Add 2 ml of Schneider’s Drosophila medium supplemented with FBS to each well and put the cells back in the incubator at 25oC. 
7.  At each time point collect a small sample of cells (10 µl) from both RNAi and control experiments and count viable cells by 
staining with trypan-blue (Sigma). Then collect the remaining cells from each well and pellet by centrifugation at 1,500 rpm for 4 
min. 
8.  Discard the medium and re-suspend the cells directly into the appropriate volume of Laemmli sample buffer to run 106 cells/lane 
of a gel.  
9.  Lyse the cells by sonication, boil for 5 min and store the protein extracts at -20oC. 
10.  At the end of the time course, subject every sample from each time point (RNAi and control experiment) to SDS-PAGE. 
11.  Transfer the proteins to nitrocellulose membranes and process for routine immunoblotting using specific primary antibodies to the 
protein of interest together with antibodies for a loading control (we use commercial anti-actin or anti-tubulin antibodies from 
Sigma). Secondary antibodies conjugated to horseradish peroxidase were detected by ECL (Amersham) according to the 
manufacturer’s instructions.  
 
Protocol 3: Phenotypic analysis after RNAi by immunofluorescence 
 
1. Grow  Drosophila S2 cells exponentially in T-flasks at 25oC in Schneider’s Drosophila medium for 4 days. 
2.  Check how many time points and how many slide chambers will be needed for the experiment (1 slide = 2 chambers per time 
point e.g. 0, 24, 48, 72, 96, 120, 144 hours: total of 7 slides, 7 chamber for specific RNAi treated cells and 7 chambers for controls).  
3.  Count viable cells by staining with trypan-blue (Sigma) using a haemocytometer and dilute in Schneider’s Drosophila medium 
(Gibco) without serum to make up the total volume needed for the experiment and for a final concentration of 106 cells/ml. 
4.  Distribute 0.5 ml of media containing 106 cells/ml into each chamber. 
5. Add  15  µg of dsRNA to one of the chambers of the slide, and an equivalent amount of control dsRNA to the control wells. Mix 
well by swirling. 
6.  Leave the cells at room temperature for 1 h to allow incorporation of the dsRNA. 
7.  Add 1 ml of Schneider’s Drosophila medium supplemented with to each chamber and incubate the slides at 25oC. 
8.  At each time point, re-suspend the cells by pipetting up and down and centrifuge the slide using appropriate racks for 15 min at 
4,000 rpm and at room temperature.  
9.  Discard the medium and immediately fix the adherent cells using appropriate conditions for the antibodies to be used (we fix the 
cells using 4 % paraformaldehyde diluted in cytoskeleton buffer: 1.1 mM Na2HPO4, 0.4 mM KH2PO4, 137 mM NaCl, 5 mM KCl, 
2 mM MgCl2, 2 mM EGTA, 5 mM Pipes, 5.5 mM glucose, pH 6.1; see ref. 33). If necessary, permeabilize the cells after fixation 
using 0.1 % Triton X-100 (Merck) diluted in cytoskeleton buffer. 
10.  Cells can now be processed immediately for immunofluorescence or alternatively can be kept in PBS at 4oC up to one week, or in 
PBS:Glycerol (60%) at -20oC for several months. 